Access by Country
Australia Naltrexone PBS Check: Item 8370M and 2026 Co-payments
PBS item 8370M covers naltrexone 50 mg tablets; 2026 maximum co-payments are $25 general and $7.70 concession.
Access by Country
Country guides that separate the product, care route, funding clue, and local questions that still need an answer.
Access by CountryNew Zealand Naltrexone Funding: June 2026 PHARMAC Check
A dated June 2026 check: Naltraccord 50 mg was fully subsidised under SA1408, with pharmacy charges and GP fees separate. Updated for the brand change of 1 November 2026.
Access by CountrySingapore Naltrexone Check: Contrave Is Registered—What About 50 mg?
Singapore's official formulary confirms Contrave, while current standalone 50 mg naltrexone supply and price remain unverified.
Access by CountryUAE Naltrexone Registry Check: What Is Actually Listed?
A dated check of the UAE drug directory: Contrave is active, standalone naltrexone was not found, and DHA guidance still recognises naltrexone clinically.